Ontology of Drug Neuropathy Adverse Events
How to cite this record FAIRsharing.org: ODNAE; Ontology of Drug Neuropathy Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.ddmatg; Last edited: Jan. 8, 2019, 1:28 p.m.; Last accessed: Aug 14 2020 1:11 a.m.
Record added: Oct. 24, 2017, 9:41 a.m.
Record updated: Feb. 20, 2018, 2:24 p.m. by The FAIRsharing Team.
Edits to 'https://fairsharing.org/FAIRsharing.ddmatg' by 'The FAIRsharing Team' at 14:24, 20 Feb 2018 (approved): 'contactName' has been modified: Before: Oliver He After: Yongqhun He Added: Removed:
Edits to 'https://fairsharing.org/FAIRsharing.ddmatg' by 'The FAIRsharing Team' at 13:44, 19 Feb 2018 (approved): 'description' has been modified: Before: ODNAE is an extension of OAE with a focus on drug-associated neuropathy adverse events. After: The Ontology of Drug Neuropathy Adverse Events (ODNAE) is an extension of OAE which serves as a knowledge base comprising drug components, chemical entities of active drug ingredients, drug mechanisms, and drug-inducing neuropathy AEs. ODNAE is a platform for building a drug-induced neuropathy knowledge base and for analyzing the underlying mechanisms of drug-induced neuropathy. The ODNAE-based methods used in this study can also be extended to the representation and study of other categories of adverse events.
No XSD schemas defined
Conditions of UseApplies to: Data use
View in BioPortal.
No guidelines defined
Models and Formats
No syntax standards defined
No identifier schema standards defined
No metrics standards defined
No Related Databases
This record is not implemented by any policy.
This record is maintained by yongqunh
Mayo Clinic, Rochester, USA (Company)
University of Michigan Medical School, USA (University)
University of Maryland, Baltimore, MD, USA (University)